(MENAFN- The Conversation) The national effort to immunise the UK population against COVID-19 has been phenomenal. In six months, more than have been given to over 36 million people. With the distribution of first and second doses going well, the British government is now considering if and when it should give people a third, booster dose.
However, so far have been . They''ve offered on when boosters will be given, who they''ll be given to, and what exactly people might receive. But while it's impossible to say for sure what will happen in the future, based on what we know about COVID-19 and the pandemic, it is possible to predict broadly how a booster programme could operate.
Undoubtedly, there's a desire to end lockdown restrictions, reopen the country and keep it open – and this is why a third vaccine dose is being considered. Reopening safely will require two key conditions to be met: firstly, that most people get vaccinated, and secondly, that the vaccines remain effective. Boosters may be needed to ensure the latter. Here's how they might work.
Who will be offered a third vaccine?
People whose earlier vaccine protection may have worn off are likely to be prioritised.
Currently, it's not certain how long COVID-19 vaccine protection lasts, though studies suggest . However, vaccine protection varies by individual and naturally wanes over time. For some people, this waning happens more rapidly, for such as old age, the effect of some chronic illness, or taking treatments that may suppress the immune system.
Consequently, a booster dose is likely to be needed for people in these high-risk groups to make sure good immune protection is maintained. Indeed, the UK's Department of Health and Social Care has said that boosters will be distributed .
Those initially prioritised for COVID-19 vaccines – the elderly and clinically vulnerable – will likely be the first to receive boosters. When might boosters start being given?
Ahead of when future waves of infection are anticipated. Epidemics of human coronaviruses are usually , typically occurring in the winter months. Thus, the ideal timing for the vaccine booster programme will be in the autumn months so that most of the vulnerable population is protected in time for any winter outbreaks.
Current efforts are targeted at immunising the UK adult population with two doses . It's likely that any vaccine booster programme will only begin afterwards. Indeed, the logistics of planning, procuring the boosters, distributing them and rolling them out is fairly complex. This may delay rollout to early 2022.
Will the booster be an updated formula?
So far, the vaccines in use in the UK are against circulating variants of the virus. On that basis, booster vaccines are likely to be the same as ones used previously.
However, a major concern is that a new variant emerges that can evade the immunity provided by existing vaccines – what's known as ''vaccine escape''.
Should an escape variant emerge, one strategy may be to boost people with the existing vaccine that has the best efficacy against it. For example, the B1351 variant identified in South Africa appears to have some escape potential, as the Oxford/AstraZeneca vaccine is at preventing mild to moderate COVID-19 when facing it. However, – still needs to be reviewed by other scientists – suggests the Pfizer/BioNTech vaccine isn''t so severely affected.
If none of the existing vaccines are sufficiently effective, then updated vaccines may be needed. However, they will take time to alter and mass produce. In the meantime, we need to closely monitor and study both the emergence of new variants as well as the effectiveness of existing vaccines against them.
Pfizer, Moderna and AstraZeneca have all started work on updated boosters to better handle the new variants. Will I get a booster from a different manufacturer?
Possibly. Combining COVID-19 vaccines that – such as Pfizer's and AstraZeneca's – could generate a more powerful and long-lasting immune response. It could also allow for greater flexibility in rolling out a third dose, which might speed things up.
However, while in theory mixing doses could give an extra boost of immunity, is still trying to work out if this actually happens. UK scientists looking at mixing the Pfizer and AstraZeneca vaccines have so far found that when combining the two. On that basis, if an individual has reacted well to one vaccine, it may be sensible for the same vaccine to be used.
Will I need another booster in the future?
It will take more time to be sure, but again, possibly yes. This is still a new pandemic, and it's how long COVID-19 immunity lasts and how strong it will be. Based on what we know about the original Sars virus, but may wane. What's not known is whether these immune responses are sufficient to protect against severe illness or death.
It may therefore be prudent for people to be re-immunised against COVID-19 on an annual basis to maintain immunity, as the coronavirus will become endemic and circulate continually. If variants continue to emerge, then continually updated vaccines may become the norm, like for seasonal flu.
There's also emerging evidence that COVID-19 vaccines don''t just protect against disease, but also of people spreading the virus by infected people carry. Vaccinations could therefore be used on an ad hoc basis to quell outbreaks and emerging epidemics.
There remain many unanswered questions, and how the global pandemic will unfold in the next year is also uncertain. Vaccine policy decisions will need to be flexible and informed by emerging evidence of vaccine effectiveness and infection trends.
MENAFN18052021000199003603ID1102097440
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.